Raymond James & Associates’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
Other funds holding ACA
RA
SAM
Raymond James & Associates's ACA Position: Q3 2024 in Review
Raymond James & Associates increased its Arcosa (ACA) stake by 2.3% in Q3 2024, buying an estimated $40.8K and bringing the position to 21,180 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2220.
Raymond James & Associates first reported a position in ACA in Q4 2018 and has held it in 24 quarters since. The position peaked at $8.4M in Q4 2019. 324 funds tracked by Wall St. Rank hold ACA as of Q3 2024.
- Raymond James & Associates held 21,180 shares of Arcosa worth $2.01M as of Q3 2024.
- Raymond James & Associates bought 467 Arcosa shares in Q3 2024, an estimated $40.8K.
- Arcosa made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2220 holding.
- Raymond James & Associates first reported a position in Arcosa in Q4 2018 and has held it in 24 quarters since.
- Raymond James & Associates's Arcosa position peaked at $8.4M in Q4 2019.
- 324 funds tracked by Wall St. Rank held Arcosa as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.